Skip to main content

Advertisement

Log in

Relationship between matrix metalloproteinase-9 and common carotid artery intima media thickness

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Atherosclerosis causes significant morbidity and mortality. Carotid intima media thickness (IMT) predicts future ischaemic strok e incidence. Matrix metalloproteinases (MMPs) play a considerable role in atherosclerosis and hold therapeutic promise as well. To investigate the relationship between serum level of matrix metalloproteinase-9 (MMP-9) and common carotid artery intima media thickness (CCA-IMT) in patients with ischaemic stroke and asymptomatic subjects. Thirty patients with a previous ischaemic stroke and 30 asymptomatic volunteers were recruited. Assessment of vascular risk factors, serum level of MMP-9 and CCA-IMT on both sides was performed. The IMT of both CCAs correlated positively with the serum MMP-9 level in asymptomatic subjects (p = 0.000), even after adjustment for other risk factors. In the patients group, this positive correlation was significant for the right but not for the left CCA (right CCA: p = 0.023, left CCA: p = 0.0284). Fasting blood sugar correlated positively with serum levels of MMP-9 in asymptomatic subjects (p = 0.005) but did not correlate positively in patients. There was no significant correlation between MMP-9 and age or other investigated laboratory risk factors in either the patient or asymptomatic groups. MMP-9 is positively correlated with CCA-IMT both in stroke patients and asymptomatic subjects. This may indicate that MMP-9 is a possible therapeutic target for stroke prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Baker AH, Zaltsman AB, George SJ, Newby AC (1998) Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest 101:1478–1487

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  2. Bendeck MP, Irvin C, Reidy MA (1996) Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res 78:38–43

    Article  PubMed  CAS  Google Scholar 

  3. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA (1994) Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75:539–545

    Article  PubMed  CAS  Google Scholar 

  4. Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Acta 1477:267–283

    Article  CAS  Google Scholar 

  5. Chau KY, Sivaprasad S, Patel N, Donaldson TA, Luthert PJ, Chong NV (2007) Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) 21:1511–1515

    CAS  Google Scholar 

  6. Choudhary S, Higgins CL, Chen IY, Reardon M, Lawrie G, Vick GW, Karmonik C, Via DP, Morrisett JD (2006) Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues. Arterioscler Thromb Vasc Biol 26:2351–2358

    Article  PubMed  CAS  Google Scholar 

  7. Clark AW, Krekoski CA, Bou SS, Chapman KR, Edwards DR (1997) Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett 238:53–56

    Article  PubMed  CAS  Google Scholar 

  8. Eldrup N, Grønholdt M-LM, Sillesen H, Nordestgaard BG (2006) Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis. Circulation 114:1847–1854

    Article  PubMed  CAS  Google Scholar 

  9. Forough R, Koyama N, Hasenstab D, Lea H, Clowes M, Nikkari ST, Clowes AW (1996) Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Circ Res 79:812–820

    Article  PubMed  CAS  Google Scholar 

  10. Forough R, Lea H, Starcher B, Allaire E, Clowes M, Hasenstab D, Clowes AW (1998) Metalloproteinase blockade by local overexpression of TIMP-1 increases elastin accumulation in rat carotid artery intima. Arterioscler Thromb Vasc Biol 18:803–807

    Article  PubMed  CAS  Google Scholar 

  11. Galis ZS, Khatri JJ (2002) Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90:251–262

    PubMed  CAS  Google Scholar 

  12. Galis ZS, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493–2503

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  13. Godin D, Ivan E, Johnson C, Magid R, Galis ZS (2000) Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model. Circulation 102:2861–2866

    Article  PubMed  CAS  Google Scholar 

  14. Higashikata T, Yamagishi M, Higashi T et al (2006) Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: results of quantitative tissue analysis using real-time RT-PCR method. Atherosclerosis 185:165–172

    Article  PubMed  CAS  Google Scholar 

  15. Johnson JL, Jackson CL, Angelini GD, George SJ (1998) Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 18:1707–1715

    Article  PubMed  CAS  Google Scholar 

  16. Jormsjö S, Ye S, Moritz J, Walter DH, Dimmeler S, Zeiher AM, Henney A, Hamsten A, Eriksson P (2000) Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ Res 86:998–1003

    Article  PubMed  Google Scholar 

  17. Kim S-J, Chung Y-K, Chung T-W, Kim J-R, Moon S-K, Kim C-H, Park Y-G (2009) Regulation of matrix metalloproteinase-9 expression between gingival fibroblast cells from old and young rats. Biochem Biophys Res Commun 378:152–156

    Article  PubMed  CAS  Google Scholar 

  18. Kornowski R, Mintz GS, Lansky AJ, Hong MK, Kent KM, Pichard AD, Satler LF, Popma JJ, Bucher TA, Leon MB (1998) Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients. Am J Cardiol 81:1298–1304

    Article  PubMed  CAS  Google Scholar 

  19. Lutgens E, Lutgens SPM, Faber BCG et al (2006) Disruption of the Cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation 113:98–107

    Article  PubMed  CAS  Google Scholar 

  20. Machado L, Kozak A, Ergul A, Hess D, Borlongan C, Fagan S (2006) Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci 7(1):56

    Article  PubMed  PubMed Central  Google Scholar 

  21. Mackinnon AD, Jerrard-Dunne P, Sitzer M, Buehler A, Von Kegler S, Markus HS (2004) Rates and determinants of site-specific progression of carotid artery intima-media thickness: the carotid atherosclerosis progression study. Stroke 35:2150–2154

    Article  PubMed  Google Scholar 

  22. Mason DP, Kenagy RD, Hasenstab D, Bowen-Pope DF, Seifert RA, Coats S, Hawkins SM, Clowes AW (1999) Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 85:1179–1185

    Article  PubMed  CAS  Google Scholar 

  23. Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121–125

    Article  PubMed  CAS  Google Scholar 

  24. Noji Y, Kajinami K, Kawashiri MA et al (2001) Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis. Clin Chem Lab Med 39:380–384

    Article  PubMed  CAS  Google Scholar 

  25. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 340:14–22

    Article  PubMed  Google Scholar 

  26. Olson FJ, Schmidt C, Gummesson A, Sigurdardottir V, Hulthe J, Wiklund O, Fagerberg B (2008) Circulating matrix metalloproteinase 9 levels in relation to sampling methods, femoral and carotid atherosclerosis. J Intern Med 263:626–635

    Article  PubMed  CAS  Google Scholar 

  27. Romero JR, Vasan RS, Beiser AS, Polak JF, Benjamin EJ, Wolf PA, Seshadri S (2008) Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: the Framingham offspring study. J Stroke Cerebrovasc Dis 17:412–417

    Article  PubMed  PubMed Central  Google Scholar 

  28. Rybakowski JK (2009) Matrix metalloproteinase-9 (MMP9)-a mediating enzyme in cardiovascular disease, cancer, and neuropsychiatric disorders. Cardiovasc Psychiatry Neurol 2009:904836

    Article  PubMed  PubMed Central  Google Scholar 

  29. Sapienza P, Di Marzo L, Borrelli V, Sterpetti AV, Mingoli A, Cresti S, Cavallaro A (2005) Metalloproteinases and their inhibitors are markers of plaque instability. Surgery 137:355–363

    Article  PubMed  Google Scholar 

  30. Somiari SB, Somiari RI, Heckman CM, Olsen CH, Jordan RM, Russell SJ, Shriver CD (2006) Circulating MMP2 and MMP9 in breast cancer—potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer 119:1403–1411

    Article  PubMed  CAS  Google Scholar 

  31. Southgate KM, Davies M, Booth RF, Newby AC (1992) Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem J 288(Pt 1):93–99

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  32. Tan C, Liu Y, Li W, Deng F, Liu X, Wang X, Gui Y, Qin L, Hu C, Chen L (2014) Associations of matrix metalloproteinase-9 and monocyte chemoattractant protein-1 concentrations with carotid atherosclerosis, based on measurements of plaque and intima-media thickness. Atherosclerosis 232:199–203

    Article  PubMed  CAS  Google Scholar 

  33. Tauth J, Pinnow E, Sullebarger JT, Basta L, Gursoy S, Lindsay J, Matar F (1997) Predictors of coronary arterial remodeling patterns in patients with myocardial ischemia. Am J Cardiol 80:1352–1355

    Article  PubMed  CAS  Google Scholar 

  34. Tayebjee MH, Tan KT, MacFadyen RJ, Lip GYH (2005) Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: Relationship to disease severity. J Intern Med 257:110–116

    Article  PubMed  CAS  Google Scholar 

  35. Wang Y, Deng X-L, Xiao X-H, Yuan B-X (2007) A non-steroidal anti-inflammatory agent provides significant protection during focal ischemic stroke with decreased expression of matrix metalloproteinases. Curr Neurovasc Res 4:176–183

    Article  PubMed  CAS  Google Scholar 

  36. Zhang Y, Stewart KG, Davidge ST (2000) Estrogen replacement reduces age-associated remodeling in rat mesenteric arteries. Hypertension 36:970–974

    Article  PubMed  CAS  Google Scholar 

  37. Zhang B, Ye S, Herrmann SM et al (1999) Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99:1788–1794

    Article  PubMed  CAS  Google Scholar 

  38. Zhou S, Feely J, Spiers JP, Mahmud A (2007) Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension. J Hum Hypertens 21:861–867

    Article  PubMed  CAS  Google Scholar 

  39. Zureik M, Beaudeux J-L, Courbon D, Bénétos A, Ducimetière P (2005) Serum tissue inhibitors of metalloproteinases 1 (TIMP-1) and carotid atherosclerosis and aortic arterial stiffness. J Hypertens 23:2263–2268

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was done using Cairo University facilities. Authors did not receive any grant or fund to accomplish this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eman H. Esmail.

Ethics declarations

Conflict of interest

All authors confirm that they have no any conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdelnaseer, M., Elfayomi, N., Esmail, E.H. et al. Relationship between matrix metalloproteinase-9 and common carotid artery intima media thickness. Neurol Sci 37, 117–122 (2016). https://doi.org/10.1007/s10072-015-2358-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-015-2358-z

Keywords

Navigation